Navigation Links
A new study examines how shared pathogens affect host populations

Many pathogens are able to infect multiple species within a community and are commonly transmitted across species. Cross-species transmission is often associated with pathogen emergence and therefore has been considered as a negative factor for humans, wildlife, and species of agricultural importance. Many pathogens like malaria, Lyme disease or West Nile encephalitis that infect multiple hosts are commonly transmitted by vectors, and their transmission rate is often thought to depend on the proportion of hosts or vectors infected (i.e. frequency dependence). A study, to appear in the July 2005 issue of The American Naturalist, by Volker H. W. Rudolf and Janis Antonovics provides an important conceptual counterexample to the idea that sharing pathogens necessarily affects host populations negatively.

They show that if there is frequency-dependent transmission, a host can be rescued from pathogen-mediated extinction by the presence of a second host with which it shares a pathogen. Sharing a pathogen among one or more alternative species may actually be limiting the spread of the pathogen in any one particular host population. Thus, an epidemic on one species may result because of loss or reduction in the abundance of species in the community, without any numerical or genetic change in the host or pathogen. Studying only the target species or the abiotic environment would not reveal the cause of the epidemic. Their results have not only important consequences for understanding the role of pathogens in species interactions but also provide a potential mechanism linking host biodiversity and ecosystem functioning.

Sponsored by the American Society of Naturalists, The American Naturalist is a leading journal in the fields of ecology and evolutionary biology and animal behavior. For more information, please see our website:

Volker H. W. Rudolf and Janis Antonovics, "Species coexistence and pathogens with frequency-depend ent transmission" 165:7 July 2005.


Source:University of Chicago Press Journals

Related biology news :

1. Bioartificial kidney under study at MCG
2. W.M. Keck Foundation funds study of friendly microbes
3. Yellowstone microbes fueled by hydrogen, according to U. of Colorado study
4. Genome-wide mouse study yields link to human leukemia
5. Clam embryo study shows pollutant mixture adversely affects nerve cell development
6. New imaging method gives early indication if brain cancer therapy is effective, U-M study shows
7. Same mutation aided evolution in many fish species, Stanford study finds
8. Sequencing of marine bacterium will help study of cell communication
9. Genetically modified rice in China benefits farmers health, study finds
10. NYU study reveals how brains immune system fights viral encephalitis
11. Loves all in the brain: fMRI study shows strong, lateralized reward, not sex, drive
Post Your Comments:

(Date:5/16/2016)... --  EyeLock LLC , a market leader of iris-based ... IoT Center of Excellence in Austin, Texas ... embedded iris biometric applications. EyeLock,s iris authentication ... with unmatched biometric accuracy, making it the most proven ... platform uses video technology to deliver a fast and ...
(Date:4/28/2016)... BANGALORE, India , April 28, 2016 ... of Infosys (NYSE: INFY ), and Samsung SDS, ... partnership that will provide end customers with a more ... payment services.      (Logo: ) ... financial services, but it also plays a fundamental part in ...
(Date:4/19/2016)... April 20, 2016 The new ... a compact web-based "all-in-one" system solution for all door ... reader or the door interface with integration authorization management ... control systems. The minimal dimensions of the access control ... the building installations offer considerable freedom of design with ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... ... 23, 2016 , ... STACS DNA Inc., the sample tracking software company, today ... Laboratory, has joined STACS DNA as a Field Application Specialist. , “I am ... and COO of STACS DNA. “In further expanding our capacity as a scientific integrator, ...
(Date:6/23/2016)... , June 23, 2016 Apellis Pharmaceuticals, ... 1 clinical trials of its complement C3 inhibitor, ... and multiple ascending dose studies designed to assess ... of subcutaneous injection in healthy adult volunteers. ... either as a single dose (ranging from 45 ...
(Date:6/23/2016)... , June 23, 2016 ... Hematology Review, 2016;12(1):22-8 ... , the peer-reviewed journal from touchONCOLOGY, Andrew ... escalating cost of cancer care is placing an ... result of expensive biologic therapies. With the patents ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... is exhibiting at the Pennsylvania Convention Center and will showcase its product’s latest ... ClinCapture will also be presenting a scientific poster on Disrupting Clinical Trials in ...
Breaking Biology Technology: